Trials / Unknown
UnknownNCT01492387
Duration of Antibiotic Therapy in Community - Acquired Pneumonia
Individualizing Duration of Antibiotic Therapy in Hospitalized Patients With Community - Acquired Pneumonia: a Non-inferiority, Randomized, Controlled Trial.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 892 (estimated)
- Sponsor
- University of Milan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the efficacy of an individualized approach to duration of antibiotic therapy based on each subject's clinical response compared to a local standard approach in patients coming from the community and who are hospitalized because of a pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Discontinuation of antibiotic therapy | Patients randomized in the Individualized Arm will be treated according to clinical response: antibiotic therapy will be discontinued 48 hours after the day that the patient reaches clinical stability, with at least 5 days of total antibiotic treatment. |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2014-12-01
- Completion
- 2015-03-01
- First posted
- 2011-12-15
- Last updated
- 2014-01-03
Locations
15 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT01492387. Inclusion in this directory is not an endorsement.